etidronic acid, 2809-21-4

Articles:

PubMed:	Biosorption of heavy metal ions onto agricultural residues buckwheat hulls functionalized with 1-hydroxylethylidenediphosphonic acid.
PubMed:	Intravenous zoledronic acid: what are the indications for male osteoporosis?
PubMed:	Effect of osteoporosis treatment on mortality: a meta-analysis.
PubMed:	Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: a phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study.
PubMed:	Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosis.
PubMed:	Compatibility of risedronate sodium tablets with food thickeners.
PubMed:	Paget disease of bone: therapeutic options.
PubMed:	Nonvertebral fracture risk reduction with nitrogen-containing bisphosphonates.
PubMed:	Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.
PubMed:	Evaluation of 41calcium as a new approach to assess changes in bone metabolism: effect of a bisphosphonate intervention in postmenopausal women with low bone mass.
PubMed:	Effect of administration site in the gastrointestinal tract on bioavailability of poorly absorbed drugs taken after a meal.
PubMed:	Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence.
PubMed:	Pharmaceutical care and community pharmacists' understanding of bisphosphonate dosing information.
PubMed:	Clinical trial of risedronate in Japanese volunteers: a study on the effects of timing of dosing on absorption.
PubMed:	An approach to postmenopausal osteoporosis treatment: a case study review.
PubMed:	Prevention and treatment of osteoporosis.
PubMed:	Bone density changes with once weekly risedronate in postmenopausal women.
PubMed:	Treatment of hypercalcemia of malignancy with bisphosphonates.
PubMed:	Food-drug interactions.
PubMed:	Risedronate: a new oral bisphosphonate.
PubMed:	Gender differences in osteoporosis treatment: a review of clinical research.
PubMed:	Timing of cyclical etidronate.
PubMed:	Prevention and treatment of osteoporosis.
PubMed:	The effect of dosing regimen on the pharmacokinetics of risedronate.
PubMed:	Evaluation of the effects of risedronate on hepatic microsomal drug metabolizing enzyme activities following administration to rats for 14 days: lack of an induction response.
PubMed:	Risedronate released for Paget's disease.
PubMed:	Bisphosphonates: preclinical aspects and use in osteoporosis.
PubMed:	Adverse effects of bisphosphonates. A comparative review.
PubMed:	Osteoporosis: pathophysiology, prevention, diagnosis, and treatment.
PubMed:	Etidronate for hypercalcemia of malignancy and osteoporosis.
PubMed:	Absorption of oral diphosphonate in normal subjects.